Renal Morbidity Following Kidney Cancer Surgery
肾癌手术后的肾脏发病率
基本信息
- 批准号:7961124
- 负责人:
- 金额:$ 15.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-15 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AwardCancer ControlCardiovascular systemChronic Kidney FailureClinicalClinical ResearchComorbidityDiagnosisEnd stage renal failureEpidemiologyEventExcisionGoalsGoldHealth Services ResearchHealthcare SystemsHeart failureHigh PrevalenceHospitalizationHypertensionIncidenceKidneyKidney NeoplasmsMalignant NeoplasmsMedicalMorbidity - disease rateMyocardial InfarctionNephrectomyNephronsOperative Surgical ProceduresOutcomePatient CarePatientsPeripheral arterial diseasePersonsPostoperative PeriodRegistriesRenal Cell CarcinomaRenal MassRenal carcinomaRenal functionReportingResearch PersonnelRiskStrokeTrainingUniversitiesVeteransanticancer researchbasecancer surgeryclinical carecohortcomparative effectivenessdisorder riskelectronic dataimprovedkidney cortexmortalityprogramspublic health relevancestandard caretumorurologic
项目摘要
DESCRIPTION (provided by applicant): The impact of significant loss of renal mass resultant from kidney cancer surgery is not fully known. Large clinical studies demonstrate that loss of kidney function correlates with an increased incidence of hospitalizations, cardiovascular events, and all-cause mortality. Patients with renal cell carcinoma (RCC) tend to be older, often have co-morbid conditions associated with lower baseline kidney function, and may be particularly sensitive to further loss of kidney function following kidney cancer surgery. Hence, there is a great need to determine the comparative effectiveness of alternative surgical approaches for RCC on kidney function and downstream clinical outcomes. The goal of this award period is for Dr. Leppert to achieve complete independence as an investigator in urologic health services research and expertise in RCC clinical outcomes. He will receive extensive training through the Clinical Research Track in the Graduate Program in Epidemiology at Stanford University, and through the specific aims of the project. The broad objective of this study is to determine the effect of kidney cancer surgery on kidney function and outcomes associated with chronic kidney disease (CKD) such as end-stage renal disease (ESRD), cardiovascular events, hospitalizations, and mortality. The specific aims of the project are to 1) establish an electronic data registry of persons that underwent kidney cancer surgery within the Veterans Affairs (VA) health care system, 2) characterize the change of kidney function due to specific types of kidney cancer surgery, and 3) to correlate the type of kidney cancer surgery received and post-operative kidney function with the risk of ESRD, conditions associated with CKD, cardiovascular events, hospitalizations, and all-cause mortality among RCC patients in the VA health care system. Ultimately, comparing these surgical strategies can provide opportunities to improve care for patients diagnosed with RCC.
PUBLIC HEALTH RELEVANCE: The impact of kidney cancer surgery on chronic kidney disease and its associated clinical outcomes is not fully known. Comparing the effect of kidney cancer surgery on kidney function will help inform treatment decisions and provide opportunities to improve care and clinical outcomes for patients diagnosed with kidney cancer.
描述(由申请人提供):肾癌手术导致的肾质量显着损失的影响尚不完全清楚。大型临床研究表明,肾功能丧失与住院、心血管事件和全因死亡率增加相关。肾细胞癌 (RCC) 患者往往年龄较大,通常患有与基线肾功能较低相关的共病,并且可能对肾癌手术后肾功能的进一步丧失特别敏感。因此,非常需要确定肾细胞癌替代手术方法对肾功能和下游临床结果的比较有效性。该奖项期的目标是让 Leppert 博士作为泌尿科健康服务研究和 RCC 临床结果专业知识的研究者实现完全独立。他将通过斯坦福大学流行病学研究生项目的临床研究轨道以及该项目的具体目标接受广泛的培训。本研究的主要目标是确定肾癌手术对肾功能以及与慢性肾脏病 (CKD) 相关的结局的影响,例如终末期肾病 (ESRD)、心血管事件、住院治疗和死亡率。该项目的具体目标是 1) 为退伍军人事务部 (VA) 医疗保健系统内接受肾癌手术的人员建立电子数据登记册,2) 描述特定类型肾癌手术导致的肾功能变化特征,3) 将接受的肾癌手术类型和术后肾功能与 ESRD 风险、CKD 相关病症、心血管事件、住院治疗和住院治疗联系起来。 VA 医疗保健系统中 RCC 患者的全因死亡率。最终,比较这些手术策略可以为改善诊断为肾细胞癌的患者的护理提供机会。
公众健康相关性:肾癌手术对慢性肾脏病及其相关临床结果的影响尚不完全清楚。比较肾癌手术对肾功能的影响将有助于为治疗决策提供信息,并为改善诊断为肾癌的患者的护理和临床结果提供机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Thomas Leppert其他文献
John Thomas Leppert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Thomas Leppert', 18)}}的其他基金
Defining Optimal Care for Urinary Stone Disease in the Veterans Health Administration
退伍军人健康管理局定义泌尿系结石的最佳护理
- 批准号:
10506323 - 财政年份:2020
- 资助金额:
$ 15.21万 - 项目类别:
Defining Optimal Care for Urinary Stone Disease in the Veterans Health Administration
退伍军人健康管理局定义泌尿系结石的最佳护理
- 批准号:
10229348 - 财政年份:2020
- 资助金额:
$ 15.21万 - 项目类别:
Personalized Life Expectancy to Encourage High Value Prostate Cancer Care
个性化预期寿命鼓励高价值前列腺癌护理
- 批准号:
10186501 - 财政年份:2017
- 资助金额:
$ 15.21万 - 项目类别:
Personalized Life Expectancy to Encourage High Value Prostate Cancer Care
个性化预期寿命鼓励高价值前列腺癌护理
- 批准号:
9768237 - 财政年份:2017
- 资助金额:
$ 15.21万 - 项目类别:
相似海外基金
Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes
使用模拟禁食饮食进行间歇性禁食以改善前列腺癌控制和代谢结果
- 批准号:
10639416 - 财政年份:2023
- 资助金额:
$ 15.21万 - 项目类别:
Multidimensional structural racism and moderating role of psychosocial resources on cancer-control behaviors in African Americans
多维结构性种族主义和心理社会资源对非裔美国人癌症控制行为的调节作用
- 批准号:
10798610 - 财政年份:2023
- 资助金额:
$ 15.21万 - 项目类别:
STAKEHOLDER ENGAGEMENT AND OUTREACH SUPPORT FOR HEALTH BEHAVIOR CHANGE AND CANCER CONTROL RESOURCES
利益相关者参与和外展支持健康行为改变和癌症控制资源
- 批准号:
10929022 - 财政年份:2023
- 资助金额:
$ 15.21万 - 项目类别:
DIVISION OF CANCER CONTROL AND POPULATION SCIENCES (DCCPS) BIOMEDICAL COMPUTING SUPPORT SERVICES_ Moonshot Support
癌症控制和人口科学部 (DCCPS) 生物医学计算支持服务_ Moonshot 支持
- 批准号:
10975530 - 财政年份:2023
- 资助金额:
$ 15.21万 - 项目类别:
Integrated delivery of cancer control interventions for adolescents and young adults living with HIV in Zambia
为赞比亚艾滋病毒感染者提供综合癌症控制干预措施
- 批准号:
10878015 - 财政年份:2023
- 资助金额:
$ 15.21万 - 项目类别:
Cancer Control and Population Sciences Research Program
癌症控制与人口科学研究计划
- 批准号:
10625755 - 财政年份:2023
- 资助金额:
$ 15.21万 - 项目类别:
The 2023 Canadian Centre for Applied Research in Cancer Control (ARCC) Conference
2023年加拿大癌症控制应用研究中心(ARCC)会议
- 批准号:
480786 - 财政年份:2023
- 资助金额:
$ 15.21万 - 项目类别:
Miscellaneous Programs
Improving access to cancer control services in low- and middle-income countries; a novel framework on policy change for pharmacists' involvement
改善低收入和中等收入国家获得癌症控制服务的机会;
- 批准号:
490927 - 财政年份:2023
- 资助金额:
$ 15.21万 - 项目类别:
Development of Combination Radiation Therapy Drugs to Improve Cancer Control Rates by Regulating DNA Damage Response Molecules
开发组合放射治疗药物,通过调节 DNA 损伤反应分子来提高癌症控制率
- 批准号:
23H02859 - 财政年份:2023
- 资助金额:
$ 15.21万 - 项目类别:
Grant-in-Aid for Scientific Research (B)